文献速递免疫规划慢病防控与筛查卫生政策与健康促进

佛罗里达各县人乳头瘤病毒疫苗接种与人乳头瘤病毒相关癌症发病率

Human Papillomavirus Vaccination and Human Papillomavirus-Associated Cancer Rates Within Florida Counties.
PubMed 文献 · Am J Prev Med · 2021-08-09

本研究利用佛罗里达州免疫登记和癌症登记数据,估计各县13-17岁青少年HPV疫苗接种率及HPV相关癌症发病率。结果显示各县接种率差异大,癌症风险与接种率呈地理聚集,北部地区接种率低且癌症发病率高。

要点

  • 佛州各县HPV疫苗启动率女性38%-100%,男性34%-96%。
  • HPV相关癌症发病率女性0-29.8/10万,男性5.4-24.1/10万。
  • 北部地区接种率低且癌症发病率高,应针对性干预。

核心结论

  • 佛州各县HPV相关癌症风险差异大,北部地区风险尤其高,低接种率与高癌症发病率地理重叠。

研究设计与样本

  • 基于佛罗里达州免疫登记(2006-2019)、癌症登记(2013-2017)和人口数据(2006-2019)的生态学研究,估计县水平HPV疫苗接种率和癌症发病率。

主要发现

  • 2018-2019年13-17岁青少年县特异性HPV疫苗启动率女性38%-100%,男性34%-96%。
  • 完成率女性20%-72%,男性24%-77%。
  • 78%的启动率和完成率处于最低三分位数的县位于佛罗里达北部。
  • 2013-2017年年均年龄调整HPV相关癌症发病率女性0-29.8/10万,男性5.4-24.1/10万。
  • 癌症发病率最高三分位数的县中,女性90%、男性77%位于北部。

临床怎么用

  • 针对疫苗接种率低且癌症发病率高的县(尤其是北部)开展针对性干预,可能降低HPV相关癌症负担。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: To direct interventions, the Florida counties with the greatest risk of current and future human papillomavirus‒associated cancers were identified by estimating county-level (1) percentages of adolescents aged 13-17 years who initiated (≥1 dose) and were up to date (2-3 doses) for the human papillomavirus vaccine and (2) human papillomavirus‒associated cancer incidence rates. METHODS: Records were obtained for human papillomavirus vaccinations from the Florida immunization registry (2006-2019), incident cancer cases from the Florida registry (2013-2017), and annual population counts from the Florida Department of Health (2006-2019). In 2020, annual county-level human papillomavirus vaccine initiation, human papillomavirus vaccine up-to-date, and age-adjusted human papillomavirus‒associated cancer incidence rates were estimated. RESULTS: Among adolescents aged 13-17 years, average 2018-2019 county-specific human papillomavirus vaccine initiation ranged from 38% to 100% for females and from 34% to 96% for males. Up-to-date estimates ranged from 20% to 72% for females and from 24% to 77% for males. The majority (78%) of counties with initiation and up-to-date estimates within the lowest tercile were located in Northern Florida. County-specific 2013-2017 annualized, adjusted human papillomavirus‒associated cancer incidence rates ranged from 0 to 29.8 per 100,000 among females and from 5.4 to 24.1 per 100,000 among males. Counties within the highest tercile for human papillomavirus‒associated cancers were primarily (90% for females and 77% for males) located in Northern Florida. CONCLUSIONS: Human papillomavirus‒associated cancer risk varies widely across Florida counties, with particularly high risk within Northern Florida. Targeting interventions toward counties with low vaccination and high cancer rates may reduce human papillomavirus‒associated cancers.

来源:Am J Prev Med,查看原文。版权归原作者所有。

引用

  1. Staras SAS, Huo T, Rothbard SM, et al. Human Papillomavirus Vaccination and Human Papillomavirus-Associated Cancer Rates Within Florida Counties. Am J Prev Med. 2021. PMID: 34384654. doi:10.1016/j.amepre.2021.05.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。